220203-23-6,MFCD21296520
Catalog No.:AA01C3VK

220203-23-6 | 4-(4-methylcyclohexyl)-4-oxobutanoic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$436.00   $305.00
- +
100mg
95%
3 weeks  
$624.00   $437.00
- +
250mg
95%
3 weeks  
$865.00   $605.00
- +
500mg
95%
3 weeks  
$1,331.00   $932.00
- +
1g
95%
3 weeks  
$1,690.00   $1,183.00
- +
2.5g
95%
3 weeks  
$3,256.00   $2,279.00
- +
5g
95%
3 weeks  
$4,790.00   $3,353.00
- +
10g
95%
3 weeks  
$7,074.00   $4,952.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01C3VK
Chemical Name:
4-(4-methylcyclohexyl)-4-oxobutanoic acid
CAS Number:
220203-23-6
Molecular Formula:
C11H18O3
Molecular Weight:
198.2588
MDL Number:
MFCD21296520
SMILES:
CC1CCC(CC1)C(=O)CCC(=O)O
Properties
Computed Properties
 
Complexity:
215  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.7  

Literature

Title: Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.

Journal: Diabetes, obesity & metabolism 20050901

Title: Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats.

Journal: European journal of pharmacology 20030822

Title: A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.

Journal: The Journal of pharmacology and experimental therapeutics 20010601

Title: A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.

Journal: The Journal of pharmacology and experimental therapeutics 20010101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:220203-23-6 Molecular Formula|220203-23-6 MDL|220203-23-6 SMILES|220203-23-6 4-(4-methylcyclohexyl)-4-oxobutanoic acid
Catalog No.: AA01C3VK
220203-23-6,MFCD21296520
220203-23-6 | 4-(4-methylcyclohexyl)-4-oxobutanoic acid
Pack Size: 50mg
Purity: 95%
3 weeks
$436.00 $305.00
Pack Size: 100mg
Purity: 95%
3 weeks
$624.00 $437.00
Pack Size: 250mg
Purity: 95%
3 weeks
$865.00 $605.00
Pack Size: 500mg
Purity: 95%
3 weeks
$1,331.00 $932.00
Pack Size: 1g
Purity: 95%
3 weeks
$1,690.00 $1,183.00
Pack Size: 2.5g
Purity: 95%
3 weeks
$3,256.00 $2,279.00
Pack Size: 5g
Purity: 95%
3 weeks
$4,790.00 $3,353.00
Pack Size: 10g
Purity: 95%
3 weeks
$7,074.00 $4,952.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01C3VK
Chemical Name: 4-(4-methylcyclohexyl)-4-oxobutanoic acid
CAS Number: 220203-23-6
Molecular Formula: C11H18O3
Molecular Weight: 198.2588
MDL Number: MFCD21296520
SMILES: CC1CCC(CC1)C(=O)CCC(=O)O
Properties
Complexity: 215  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.7  
Literature fold

Title: Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.

Journal: Diabetes, obesity & metabolism20050901

Title: Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats.

Journal: European journal of pharmacology20030822

Title: A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.

Journal: The Journal of pharmacology and experimental therapeutics20010601

Title: A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.

Journal: The Journal of pharmacology and experimental therapeutics20010101

Building Blocks More >
1955498-39-1
1955498-39-1
7,8-difluoro-3-nitroquinolin-4-ol
AA01C404 | MFCD27974898
329704-29-2
329704-29-2
1,4,5-Oxadiazepane hydrochloride
AA01C44G | MFCD28125612
1817003-33-0
1817003-33-0
methyl 1-benzyl-4-cyanopiperidine-4-carboxylate
AA01C499 | MFCD29763092
1819968-78-9
1819968-78-9
tert-butyl 1,4,5-oxadiazepane-4-carboxylate
AA01C4EI | MFCD31615897
1955498-69-7
1955498-69-7
2-(aminomethyl)-3,4-dihydroquinazolin-4-one dihydrochloride
AA01C4IV | MFCD29763169
58121-91-8
58121-91-8
2,3,4,5-tetrahydro-1,5-benzothiazepine hydrochloride
AA01C4N1 | MFCD01663183
1566333-08-1
1566333-08-1
quinolin-5-ylmethanesulfonamide
AA01C4SY | MFCD26064803
1909317-44-7
1909317-44-7
3-(2-ethyl-1h-imidazol-1-yl)butanoic acid hydrochloride
AA01C4X8 | MFCD29763251
439291-57-3
439291-57-3
4-fluoro-2-(methylsulfanyl)aniline
AA01C51S | MFCD16744398
1358782-67-8
1358782-67-8
1-(piperidin-4-yl)cyclopropan-1-ol
AA01C55T | MFCD26938039
Submit
© 2017 AA BLOCKS, INC. All rights reserved.